Geron | GERN - Operating Expenses

Stock Price
1.69
Daily Change
0.11 6.65%
Monthly
-6.39%
Yearly
-3.16%
Q1 Forecast
1.53

Geron reported $58.8M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Amgen USD 5.9B 773M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Cassava Sciences USD 11.86M 2.23M Sep/2025
Cytokinetics USD 196.12M 27.43M Dec/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Exelixis USD 362.75M 21.35M Dec/2025
Genmab DKK 565M 38M Jun/2025
Geron USD 58.8M 2.31M Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
MacroGenics USD 67M 8M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Novavax USD 218.53M 34.86M Sep/2024